作者: H. Javelot , L. Weiner
DOI: 10.1016/J.ENCEP.2020.08.001
关键词:
摘要: Although the "panic" word has been abundantly linked to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) pandemic in press, scientific literature very few studies have considered whether current epidemic could predispose onset or aggravation of panic attacks disorder. Indeed, most thus far focused on risk increase and other psychiatric disorders as a consequence epidemic, such obsessive-compulsive disorder (OCD), post-traumatic stress (PTSD), generalized anxiety (GAD). Yet, disorder, especially subtype with prominent symptoms, which is characterized by fear response conditioning interoceptive sensations (e.g., respiratory), hypervigilance these signals, be expected situation. coughs dyspnea, are among commonly associated (59-82% 31-55%, respectively), symptoms poor illness prognosis. Hence, given that some etiological maintenance factors disorder - i.e., abnormal breathing patterns attributable not COVID-19 (coronavirus disease 2019), well towards abnormalities - are supposedly more prevalent, one expect an increased following people who were affected virus, but also those not. In comorbidity (i.e., COVID-19), it particularly important aware hypokalemia specific at-risk situations prescriptions. For instance, case salbutamol prescription, might overly used patients COVID-19, presenting diarrhea vomiting. Hypokalemia torsade de pointe; thus, caution required when prescribing psychotropic drugs, antidepressants citalopram escitalopram, first-line treatments for hydroxyzine, aiming at relief. The results reviewed here highlight importance considering further investigating impact diagnosis treatment (alone comorbid COVID-19).